PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Hospitals and diagnostic centers - Market size and forecast 2018-2023 • Blood bank centers - Market size and forecast 2018-2023 • Others - Market size and forecast 2018-2023 • Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2018-2023 • Europe - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • Bio-Rad Laboratories, Inc. • Danaher • F. Hoffmann-La Roche Ltd. • Sysmex Corporation PART 14: APPENDIX • Research methodology • List of abbreviations PART 15: EXPLORE TECHNAVIO   Exhibit 01: Global healthcare market Exhibit 02: Segments of global healthcare market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: End-user - Market share 2018-2023 (%) Exhibit 18: Comparison by end-user Exhibit 19: Hospitals and diagnostic centers - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Hospitals and diagnostic centers - Year-over-year growth 2019-2023 (%) Exhibit 21: Blood bank centers - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Blood bank centers - Year-over-year growth 2019-2023 (%) Exhibit 23: Others - Market size and forecast 2018-2023 ($ millions) Exhibit 24: Others - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by end-user Exhibit 26: Customer landscape Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Blood component required for clotting factor deficiency includes: Exhibit 40: Impact of drivers and challenges Exhibit 41: Instances of blood use Exhibit 42: Vendor landscape Exhibit 43: Landscape disruption Exhibit 44: Vendors covered Exhibit 45: Vendor classification Exhibit 46: Market positioning of vendors Exhibit 47: Abbott - Vendor overview Exhibit 48: Abbott - Business segments Exhibit 49: Abbott - Organizational developments Exhibit 50: Abbott - Geographic focus Exhibit 51: Abbott - Segment focus Exhibit 52: Abbott - Key offerings Exhibit 53: Bio-Rad Laboratories, Inc. - Vendor overview Exhibit 54: Bio-Rad Laboratories, Inc. - Business segments Exhibit 55: Bio-Rad Laboratories, Inc. - Organizational developments Exhibit 56: Bio-Rad Laboratories, Inc. - Geographic focus Exhibit 57: Bio-Rad Laboratories, Inc. - Segment focus Exhibit 58: Bio-Rad Laboratories, Inc. - Key offerings Exhibit 59: Danaher - Vendor overview Exhibit 60: Danaher - Business segments Exhibit 61: Danaher - Organizational developments Exhibit 62: Danaher - Geographic focus Exhibit 63: Danaher - Segment focus Exhibit 64: Danaher - Key offerings Exhibit 65: F. Hoffmann-La Roche Ltd. - Vendor overview Exhibit 66: F. Hoffmann-La Roche Ltd. - Business segments Exhibit 67: F. Hoffmann-La Roche Ltd. - Organizational developments Exhibit 68: F. Hoffmann-La Roche Ltd. - Geographic focus Exhibit 69: F. Hoffmann-La Roche Ltd. - Segment focus Exhibit 70: F. Hoffmann-La Roche Ltd. - Key offerings Exhibit 71: Sysmex Corporation - Vendor overview Exhibit 72: Sysmex Corporation - Business segments Exhibit 73: Sysmex Corporation - Organizational developments Exhibit 74: Sysmex Corporation - Geographic focus Exhibit 75: Sysmex Corporation - Key offerings Exhibit 76: Validation techniques employed for market sizing

Abbott Bio-Rad Laboratories, Inc. Danaher F. Hoffmann-La Roche Ltd. Sysmex Corporation